1 / 9

MU Family Medicine Algorithms

MU FCM 7/2/07 Version 1. MU Family Medicine Algorithms.

logan-franklin
Download Presentation

MU Family Medicine Algorithms

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MU FCM 7/2/07 Version 1 MU Family Medicine Algorithms • Algorithms/Pathways are based on national guidelines with modification for local practice. They do not replace clinical judgment, and should be modified as needed for best individual patient care. The goal is to improve care, not mandate treatment. Feedback is welcome, please email comments to hoganmt@missouri.edu • Algorithms: • Glycemic control/Diabetes • Coronary Artery Disease (CAD) • Hypertension • Hyperlipidemia • Heart Failure

  2. MU FCM 7/2/07 Version 1 Glycemic Control A Adult DM type 2 Diet and exercise, Metformin 500 mg - 2000 mg/d(!!- renal ds, Check Creat q 12 mos)/ No 2-3 mos A1c > 7?. Monitor q 6 mos Yes Sulfonylurea - Glipizide 2.5 mg/d, max 20 mg/d , $ OR Add Glitazone-Actos 15mg/d, max 45mg/d (no hypoglycemia)!! – HF or heart disease , Check hepatic fx 3- 6 mos OR (esp if A1C> 9) Basal Insulin 10-20 u /day (Lantus pm or NPH ($) BID), titrate per fasting glucose (most effective) B 2-3 mos A1c > 7?. No Monitor q 6 mos Yes !! = Caution $ = cost preferred Pathway does not replace clinical judgment and should be modified as needed for individual patients. Maximize combination Rx, And/or intensify insulin

  3. MU FCM 7/2/07 Version 1 Stable CAD Treatment A Stable CAD Non Vasospastic, no secondary causes (thyroid, O2, Anemia, etc) Risk factor control: BP , Lipids , DM B C D Lifestyle Modification: Stop Smoking; Diet (w/ omega-3 fatty acids), Exercise, Wt maint/reduction, NTG 0.4 mg SL prn and: Aspirin 81 mg po qd!! – bleeding or, if stent: Plavix 75 mg po qd!! Bleeding, $$ • B Blockers - Metoprolol 50-400 mg/d (post MI) • ACE inhibitors/ARB - Lisinopril 10-80 mg/d (LVEF < 40, post MI, DM) Pathway does not replace clinical judgment and should be modified as needed for individual patients. !! = Caution $$= cost issue Revascularization? If L main, 3 vessel ds, > sx or other reason

  4. MU FCM 7/2/07 Version 1 A Hypertension BP >140/90 (130/80 if DM or renal dx), no secondary cause Lifestyle modifications – wt loss, DASH diet, activity, NaCl, Alcohol Other disease/indication No other disease 1. Diuretics: HCTZ 12.5-25 mg/d, then 2. B Blockers: Metoprolol 25-400 mg/d or ACE-I :Enalapril 5 -40 mg/d or lisinopril 10-80 mg/d 3. Long Acting Ca Channel Blocker: Felodipine 5-10 mg/d 4. ARB: Losartan 25 – 100 mg/d , $$ Adjust therapy every 2-8 weeks as needed DM: ACE-I Renal insufficiency- ACE-I CAD: ACE-I, B Blocker post MI Heart Failure – ACE-I or ARB , + diuretic Elderly Systolic HTN – diuretic Post MI, Angina, atrial tachycardia/fib, tremor, hyperthyroid, migraine, preop– B Blocker Adjust therapy every 2-8 weeks as needed B If not meeting targets , consider adherence, referral, or further evaluation. !! = Caution $$= cost issue Pathway does not replace clinical judgment and should be modified as needed for individual patients.

  5. MU FCM 7/2/07 Version 1 HTN & Other disease issues A B Back to HTN guideline Pathway does not replace clinical judgment and should be modified as needed for individual patients.

  6. MU FCM 7/2/07 Version 1 A Hyperlipidemia Treatment Males > Age 40, Females > 45 LDL > 130 Or Chol/HDL > 5 Lifestyle Mods: Diet, Exercise, Wt, Smoking, BP , mod Etoh, fish oil, Benecol B Re-evaluate q 2 months, if no response: Statins:Atorvastatin 10-80 mg/d or Simvastatin 10-80mg/d to target LDL by Framingham risk group: < 5 % : 190 Add ASA 81 mg/d if male & > 5% 5-10% : 160 10-20% : 130 > 20% : 100 !! * Watch for myopathy, check FLP & liver enzymes at 6-12 weeks C Pathway does not replace clinical judgment and should be modified as needed for individual patients. !! = Caution * = check X, baseline and freq shown

  7. Class 1 = no Sx Class 2 = Mild Sx Class 3 = Moderate w/ Exercise limits Class 4 = Severe, unable to do physical activities MU FCM 7/2/07 Version 1 A Heart Failure LV Systolic Dysfunction Ejection Fraction < 50% Or prior exacerbation of Systolic HF Control DM, HTN, Lipids, Daily weight, Weight loss, Home BP, Low Na Diet, Exercise as tolerated, Smoking Cessation, Etoh/drug cessation, Stop contraindicated meds (TZD, NSAIDs, CCB, Antiarrhythmics), Flu/pneumovax prn Symptomatic? Edema/dyspnea No Yes Mild Sx with HTN & CrCl > 40 : HCTZ 12.5-25 mg/d OR Moderate Sx or CrCl <40, Furosemide 20-40 mg/d, max 80 mg BID * lytes, BP, Creat in 1 week and with any change !! = Caution * = check X, baseline and freq shown @ = Push to Max Dose as tolerated ACE-I :Enalapril 2.5 -20 BID or lisinopril 2.5-40 mg QD @ !! = renovascular ds, Cr > 3, K+, pregnant If no volume overload > 1 mon and no contraindications: B Blockers: Toprol XL 12.5-200 mg/d or Bisoprolol 1.25-10 mg/d @ Class 3 hospitalized or Class 4: Creat < 2.5 male, < 2.0 female, And K+ < 5.0 : Start Spironolactone 12.5 -25mg/d or QOD * K+ weekly , stop oral K+ prn Pathway does not replace clinical judgment and should be modified as needed for individual patients. If continued symptoms, no contraindications: Digoxin 0.125 (age > 70, renal ds, low BMI) to 0.25 mg/d Target dig level 0.5 – 1 ng/ml Refer to cardiology if symptoms persist or EF < 30-35% or Class 4

  8. Adult (>18) Depression A MU FCM 8/17/07 Version 1 • PHQ9 Assess (including suicide risk & bipolar MDQ ref), select and initiate therapy • A. Mild / Moderate - Pharmacotherapy or psychotherapy (PHQ9 10-19) • Major - Pharmacotherapy with psychotherapy (PHQ9 > 20) B Initiate therapy with SSRI - !fluoxetine 20 mg (10 -80 mg) or citalopram 20 mg (10 -60 mg) Exercise, Pt education: response expectations, followup ~ 1 week, at least 4 total contacts/12 weeks, referral options 4-6 weeks followup Clearly better: PHQ decrease > 5 or more Somewhat better: PHQ decrease 2-4 Not better: PHQ decrease < 1 Not Better Continue Therapy, reassess ~ 4-12 weeks Adjust therapy Increase dose and/or psychotherapy change Reassess 1-6 weeks Adjust therapy, assess adherence Maximize dose , consider psychotherapy change, reassess 1-6 weeks Not Better Better Full Symptom Remission? (PHQ < 10) Better Not Better Continue Treatment Total ~ 6-9 months Add medication bupropion 200-450 mg/day or change to venlafaxine 150-375 mg/day ?? Consider referral Full Symptom Remission? (PHQ < 10) Discontinue Treatment, Educate re: relapse, or maintenance if > 3 total depressive episodes ! Reassess suicide risk, Not for Bipolar patients, Consider lower dosages for elderly

  9. MU FCM 8/17/07 Version 1 A Osteoarthritis Non- Pharmacologic methods: Self management, Exercise or Physical therapy, Weight loss Pain & functional assessment each visit Acetaminophen up to 1 gm po QID ! Knee - Consider Orthotics (lateral wedge [podiatry], taping [PT]), consider trial of glucosamine 1500 mg/d Hands – splint for thumbs Consider topical Capsaicin – 0.025 % cream to skin TID/QID Knee - If knee joint effusion present, consider aspiration and intra-articular corticosteroids 40 mg Triamcinolone NSAID: Naproxen 250 - 500 mg po BID or Naproxen Sodium 220-550 mg po BID or Salsalate 1500 mg po BID If GI risk factors (Age > 65, Hx PUD/GI Bleed, Steroid, ASA, or warfarin use, smoker, EtOH use) may add omeprazole 20 mg po daily If renal ds, no response, or age > 65, consider Tramadol 50 mg daily to QID, or Opiates: Acetaminophen/codeine 30 mg QID or Acetaminophen/hydrocodone 5 mg 1-2 tabs QID If no response, consider change of NSAID (Diclofenac 50 mg BID) or EC Aspirin 650 mg TID or COX 2 inhibitor (Celecoxib 200 mg daily) Knee – consider intra-articular Synvisc 2 ml weekly X 3 weeks Specialist referral ! –Caution with long term use/liver ds

More Related